Today: 7 February 2026
Subscribe

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

Lululemon shares slipped 0.6% to $211.30 after founder Chip Wilson launched a proxy fight for board seats. The board said it will review Wilson’s nominees and issue a recommendation before the 2026 annual meeting. The move follows CEO Calvin McDonald’s decision to step down Jan. 31, with two executives named interim co-CEOs. Wilson holds a 4.27% stake and is acting alone, according to Reuters.
30 December 2025
·
Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

Texas Instruments shares hovered near $176 after Weebit Nano licensed its ReRAM memory technology to the chipmaker for embedded processing chips. The stock slipped 0.01% to $175.67 in afternoon trading. The deal covers IP licensing and technology transfer, with Weebit’s ReRAM qualified for automotive-grade reliability. Trading volume was muted as investors digested the Fed’s latest meeting minutes.
30 December 2025
··
Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

NEW YORK, December 30, 2025, 14:45 ET — Regular session Arcutis Biotherapeutics shares fell 2.9% to $27.74 in afternoon trading on Tuesday, after moving between $27.72 and $28.65. Volume was about 0.6 million shares. The drop outpaced broader biotech gauges, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.1%. That matters for Arcutis because it trades as a growth story tied to one product franchise, leaving the stock prone to outsized moves when sentiment sours across biotech and high-multiple names. Arcutis is a commercial-stage medical dermatology company whose main product, Zoryve
30 December 2025
·
Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti Computing shares rose 0.3% to $22.34 Tuesday afternoon after swinging 3% intraday. IonQ gained 1.2% and D-Wave Quantum advanced 1.6%, while the broader market was flat. Trading was thin ahead of year-end, with investors rotating within technology. The Federal Reserve’s December minutes showed policymakers split on further rate cuts.
30 December 2025
·····
Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Ares Management shares dropped 3.1% to $163.85 Tuesday afternoon, underperforming rivals as fresh Federal Reserve minutes showed policymakers split on future rate cuts. A Reuters column noted shrinking yield premiums in private credit, a core Ares business, as public markets regain ground. About 966,000 Ares shares traded, with the stock hitting a low of $163.49. Blackstone was flat; Apollo, KKR, and Carlyle edged down less than 1%.
30 December 2025
··
AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

AT&T shares rose 0.1% to $24.80 Tuesday afternoon as the broader market remained subdued ahead of Federal Reserve minutes. The stock traded in a narrow range, with peers Verizon and T-Mobile also slightly higher. Investors are watching for AT&T’s Jan. 28 earnings and updates on satellite connectivity with AST SpaceMobile. The 10-year Treasury yield edged up to 4.134%.
30 December 2025
·····
Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

NEW YORK, December 30, 2025, 2:22 PM ET — Regular session Freeport-McMoRan shares rose about 0.5% to $51.75 in afternoon trading on Tuesday, after swinging between $50.87 and $52.67 earlier in the session. The move matters because Freeport’s earnings tend to track copper prices closely. When the metal rises, miners typically see higher revenue per pound sold, which can lift cash generation. Copper’s year-end rally has put the spotlight back on supply tightness and demand tied to electrification and the buildout of power-hungry data centers. That backdrop has helped keep interest in large, liquid copper names such as Freeport. U.S.
30 December 2025
··
Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Karman Holdings shares fell 3.6% to $74.81 in New York afternoon trading Tuesday, underperforming the broader market after a $258.7 million outflow from the SPDR S&P Aerospace & Defense ETF. The stock touched a session low of $74.21, with about 465,000 shares traded. Investors are watching for signs of stabilization ahead of the company’s next quarterly update.
30 December 2025
··
CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH shares fell 1.1% to $126.01 in New York Tuesday after the company disclosed buying 31,100 shares Monday under its U.S. buyback program. The repurchases, part of a $300 million plan, came as markets traded in thin year-end conditions. Investors awaited Federal Reserve minutes due later in the day. Other U.S.-listed aggregates producers also slipped.
30 December 2025
·
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

Charles Schwab shares fell 0.6% to $100.69 in afternoon trading Tuesday, with rivals Interactive Brokers and Robinhood also lower. Investors awaited Federal Reserve minutes due later in the day for signals on rate policy. A regulatory filing showed Schwab executive Jonathan Beatty exercised options and a related trust sold 2,000 shares at about $102.01. Schwab’s fourth-quarter results are expected Jan. 21.
30 December 2025
·····
1 … 656 657 658 659 660 … 1,634

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop